Table 4.
Quartiles of AIP | Q1 | Q2 | Q3 | Q4 | P for trend |
---|---|---|---|---|---|
Cases | 107 | 114 | 185 | 258 | — |
Prevalence (%) | 5.92 | 6.48 | 10.37 | 15.48 | — |
Model 1 | 1.00 (reference) | 1.10 (0.84–1.45) | 1.84 (1.44–2.36)∗∗∗ | 2.91 (2.30–3.69)∗∗∗ | <0.001 |
Model 2 | 1.00 (reference) | 1.17 (0.86–1.55) | 1.95 (1.51–2.52)∗∗∗ | 3.21 (2.52–4.10)∗∗∗ | <0.001 |
Model 3 | 1.00 (reference) | 1.04 (0.77–1.40) | 1.65 (1.25–2.17)∗∗∗ | 2.58 (1.97–3.38)∗∗∗ | <0.001 |
Model 4 | 1.00 (reference) | 1.01 (0.75–1.37) | 1.59 (1.20–2.10)∗∗∗ | 2.53 (1.93–3.33)∗∗∗ | <0.001 |
Model 5 | 1.00 (reference) | 1.00 (0.74–1.37) | 1.59 (1.20–2.11)∗∗∗ | 2.55 (1.94–3.35)∗∗∗ | <0.001 |
Odds ratio (95% CI) for prevalent hyperuricemia by quartiles of AIP in longitudinal analysis. The adjusting variables were the same as Table 2. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.